Skip to main content
Equibles

ATS · ATS Corp /ATS · Earnings Call Transcripts & Audio

Track ATS — free

Use ATS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ATS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$19.20 +0.17 (+0.89%) At close · Sep 11
Rebalance outlook locked
Market Cap
$1.88B
Shares
98.13M

ATS Corp /ATS Earnings Call Transcripts

Quarterly earnings calls for ATS Corp /ATS (ATS), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Conference
Investor event
2026-09-10
ATS Corp /ATS (ATS) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY27 · Q1
2026-08-06
ATS Corp /ATS (ATS) Q1 2027 Earnings Call Transcript
Positive tone Life Sciences / Radiopharma growth Fixed cost transformation program (Europe) Portfolio review and margin expansion path
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q4
2026-05-28
ATS Corp /ATS (ATS) Q4 2026 Earnings Call Transcript
Positive tone Margin Expansion and Capital Efficiency Life Sciences / Radiopharma Growth Portfolio Reorganization / Transportation Exit
Results not yet reported
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-03-03
ATS Corp /ATS (ATS) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-02-04
ATS Corp /ATS (ATS) Q3 2026 Earnings Call Transcript
Confident tone Order Bookings and Backlog Life Sciences and Radiopharma Services and Aftermarket Mix
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2025-11-05
ATS Corp /ATS (ATS) Q2 2026 Earnings Call Transcript
Positive tone Order Backlog and Bookings Life Sciences and Radiopharma Growth Energy and Nuclear Opportunity
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q3
2025-02-05
ATS Corp /ATS (ATS) Q3 2025 Earnings Call Transcript
Positive tone Order bookings and backlog Margin expansion and ABM M&A and integration
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2024-11-06
ATS Corp /ATS (ATS) Q2 2025 Earnings Call Transcript
Positive tone Life Sciences strength M&A and integration Transportation/EV challenges
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-05-16
ATS Corp /ATS (ATS) Q4 2024 Earnings Call Transcript
Positive tone Record financial results and backlog Life Sciences growth and GLP-1 opportunity M&A pipeline and integration
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-02-07
ATS Corp /ATS (ATS) Q3 2024 Earnings Call Transcript
Positive tone Life Sciences & Auto-Injectors / GLP-1 M&A and Acquisitions Order Bookings & Backlog
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-08-09
ATS Corp /ATS (ATS) Q1 2024 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q3
2022-12-31
ATS Corp /ATS (ATS) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-08-10
ATS Corp /ATS (ATS) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-05-19
ATS Corp /ATS (ATS) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–14 of 14 earnings calls
Key facts CIK 1394832 CUSIP 00217Y104 13F (30d) 51 filings 49 filers Visit website Investor relations